Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 2/20 | 0.43 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.43 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.39 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.39 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.39 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.39 |
| ▸ | PRKAA1 | Q13131 | 1/20 | 0.39 |
| ▸ | PRKAB1 | Q9Y478 | 1/20 | 0.39 |
| ▸ | TYMP | P19971 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL888001 | 0.86 | ADORA3 (0.45) | ADORA2AADORA2BADORA1ADORA3PRKAG1 | |
| SCHEMBL7873202 | 0.85 | ADORA2A (0.42) | ADORA2AADORA2BPRMT6ADORA1ADORA3 | |
| SCHEMBL439196 | 0.83 | ADORA2A (0.54) | ADORA2AADORA2BADORA1ADORA3PRKAG1 | |
| SCHEMBL30901148 | 0.83 | ADORA2A (0.54) | ADORA2AADORA2BADORA1ADORA3PRKAG1 | |
| SCHEMBL2112014 | 0.83 | ADORA2A (0.48) | ADORA2AADORA2BADORA1ADORA3PRKAG1 | |
| Hydroquinone SCHEMBL7070523 | 0.82 | PRMT6 (0.41) | ADORA2AADORA2BPRMT6ADORA1ADORA3 | |
| SCHEMBL4434106 | 0.81 | ADORA2A (0.39) | ADORA2AADORA2BPRMT6ADORA1ADORA3 | |
| SCHEMBL1070361 | 0.81 | ADORA2A (0.49) | ADORA2AADORA2BPRMT6ADORA1PRKAG1 | |
| SCHEMBL9294052 | 0.81 | ADORA2A (0.49) | ADORA2AADORA2BADORA1ADORA3PRKAG1 | |
| SCHEMBL887980 | 0.81 | ADORA2A (0.39) | ADORA2AADORA2BPRMT6ADORA1ADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6756496-B1 | SUCH AS TRIETHYLAMMONIUM-5'-DIMETHOXYTRITYL-3'-THYMIDINE-HYDROGEN PHOSPHONONDITHIOATE FOR USE AS ANTIVIRAL AND ANTICANCER AGENTS | ISIS PHARMACEUTICALS, INC. | 2004-06-29 | — | — | US | claimed |
| EP-0360609-A2 | Novel hydrogen phosphonodithioate compositions | GILEAD SCIENCES, INC. (US) | 1990-03-28 | — | — | EP | claimed |